Isotiorga

Isotretinoin, the active ingredient in Isotiorga, is a retinoid presented as an oral formulation for oral use. It is indicated for the treatment of severe nodular acne and acne vulgaris in patients who have not responded adequately to conventional therapies.

GNH USA supplies Isotiorga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Isotiorga (isotretinoin) is used in dermatology to manage severe forms of acne.

- Severe nodular acne: reduces inflammatory lesions and prevents new nodule formation. - Acne vulgaris: improves overall skin clearance and decreases comedonal lesions. - Cystic acne: diminishes deep, painful cysts and promotes faster healing.

Isotiorga may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and mucous membranes: increased dryness of skin, lips and eyes. - Cheilitis: cracking and inflammation of the lips. - Photosensitivity: heightened skin sensitivity to sunlight. - Elevated liver enzymes: mild, transient increases in hepatic transaminases.

Serious or Rare Side Effects: - Teratogenicity: severe birth defects if exposure occurs during pregnancy. - Depression and suicidal ideation: mood changes requiring immediate medical attention. - Pancreatitis: inflammation of the pancreas, presenting with abdominal pain. - Severe hypertriglyceridemia: marked rise in blood triglyceride levels.

Before initiating therapy, clinicians should evaluate specific safety considerations.

- Pregnancy: contraindicated; isotretinoin is teratogenic (Category X). - Liver function: monitor hepatic enzymes regularly during therapy. - Lipid profile: check triglyceride and cholesterol levels periodically. - Vitamin A supplementation: avoid concurrent use to prevent hypervitaminosis A. - Contraception: ensure effective birth control for both sexes throughout treatment and for one month after discontinuation. - Store at room temperature: keep below 25 °C in the original container, protect from moisture and light.

Isotiorga can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements: additive toxicity leading to hypervitaminosis A. - Other systemic retinoids: cumulative teratogenic and mucocutaneous effects. - Oral contraceptives: may reduce isotretinoin efficacy, necessitating alternative contraception. - St. John’s wort: may decrease isotretinoin plasma concentrations.

Moderate Interactions (Monitor Closely): - Ketoconazole and other azole antifungals: may raise isotretinoin levels; monitor liver function. - Corticosteroids: combined use can heighten risk of pseudotumor cerebri. - Diuretics: may affect electrolyte balance; observe serum electrolytes.